
51 - 200 employees
Founded 2019
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Definium Therapeutics is a clinical-stage biotechnology company developing precision psychedelic-derived therapeutics for psychiatric and neurodevelopmental disorders. The company focuses on pharmaceutically optimized formulations of lysergide (LSD) and an R-enantiomer of MDMA to treat conditions such as major depressive disorder, generalized anxiety disorder, and core symptoms of autism spectrum disorder, advancing candidates through preclinical and clinical trials with a science-led, evidence-backed approach.
🔥 0 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Definium Therapeutics is a clinical-stage biotechnology company developing precision psychedelic-derived therapeutics for psychiatric and neurodevelopmental disorders. The company focuses on pharmaceutically optimized formulations of lysergide (LSD) and an R-enantiomer of MDMA to treat conditions such as major depressive disorder, generalized anxiety disorder, and core symptoms of autism spectrum disorder, advancing candidates through preclinical and clinical trials with a science-led, evidence-backed approach.
• Develop and execute end-to-end strategies for Expanded Access Programs and late-stage studies across Definium’s portfolio • Lead global Expanded Access Program and late-stage development strategy aligned with asset lifecycle objectives, patient access goals, and regulatory expectations • Partner with cross-functional teams to integrate Expanded Access Program and late-stage clinical activities into overall asset strategy • Lead Expanded Access Program development and implementation, including protocol development, eligibility criteria, safety oversight, and operational execution • Ensure Expanded Access Programs are compliant, scalable, ethically sound, and aligned with regulatory guidance • Consult on benefit-risk assessment, safety monitoring, and ongoing program evaluation • Support late-stage clinical evidence generation strategy, including real-world evidence, long-term safety, effectiveness, and treatment differentiation • Lead design, planning, and execution of Phase 4 and investigator-initiated clinical evidence programs • Ensure program designs address regulatory commitments, payer needs, and scientific gaps • Collaborate on clinical content for regulatory submissions and interactions • Provide clinical input into Investigator Brochures and clinical study reports • Work with Clinical Operations, Clinical Development, Data Management, Biostatistics, Pharmacovigilance, and Project Management to ensure high-quality execution • Maintain relationships with investigators, advisors, and external experts • Provide clinical leadership within matrix teams
• Doctoral degree required (MD, PhD, PharmD, PsyD) • 6-8+ years of clinical development experience in the pharmaceutical or biotechnology industry • Demonstrated experience leading Expanded Access programs and late-stage, post-approval programs • Experience selecting and managing third-party vendors to support operational functions of Expanded Access and late-stage evidence programs • CNS clinical development experience in psychiatry strongly preferred • Experience with budget ownership to include forecasting tracking, and managing across multiple programs • Working knowledge of expanded access program requirements, clinical development, regulatory pathways, and lifecycle management • Proven ability to translate strategy into execution in resource-constrained environments • Track record of effective cross-functional leadership and external stakeholder engagement • Ability to operate with diplomacy, influence without authority, and command credibility with senior leaders and external experts • Excellent verbal and written communication skills • Self-motivated, adaptable, and comfortable balancing strategic thinking with hands-on contribution • Comfortable rolling up sleeves while maintaining a strategic perspective • Energized by innovation in clinical research and patient-centric access models • Thrives in a fast-paced, evolving environment with high accountability • Acts as a role model for scientific excellence, integrity, and collaboration
• 100% paid health benefits including Medical, Dental and Vision for you and your dependents • 401(k) program with company match and vesting after the turn of the first month after your start date • Flexible time off • Generous parental leave and some fun fringe perks! • Additional compensation, including bonus and equity may be available
Apply Now🔥 14 minutes ago
Executive Director leading Cellular Therapy Account Managers across the Eastern U.S. for Immatics’ first TCR T-cell therapy launch. Building Authorized Treatment Center partnerships and patient pathways.
🔥 35 minutes ago
Fiserv fintech director leading bank relationship managers across Midwest remote locations. Driving client retention, renewals, revenue growth, and strategic financial-institution partnerships.
🔥 1 hour ago
Used Vehicle Director leading used-car sales, inventory, pricing, and trade strategy across AutoNation dealerships in Texas. Driving market-wide performance, compliance, and operational excellence.
🔥 1 hour ago
Analytics Director leading reporting strategy, dashboards, data integrity, and analytics teams. Savista helps healthcare organizations improve revenue-cycle performance, clinical care, and patient experiences.
🔥 1 hour ago
Portfolio Manager expanding ICF’s FEMA Public Assistance and Recovery business across designated U.S. regions. Leading capture strategy, client acquisition, proposals, and growing portfolio delivery.
🇺🇸 United States – Remote
💵 $131.3k - $223.1k / year
💰 $30M Grant on 2021-03
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor